NEUROPATHIX, INC. Net Income (Loss) Available to Common Stockholders, Basic
NEUROPATHIX, INC. reported Net Income (Loss) Available to Common Stockholders, Basic of -$4.54 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-30.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2021-03-30
- NEUROPATHIX, INC. net income (loss) available to common stockholders, basic for the quarter ending 2020-12-31 was -$1.56M.
- NEUROPATHIX, INC. net income (loss) available to common stockholders, basic for the quarter ending 2020-09-30 was -$610.81K.
- NEUROPATHIX, INC. net income (loss) available to common stockholders, basic for the quarter ending 2020-06-30 was -$2.06M.
- NEUROPATHIX, INC. net income (loss) available to common stockholders, basic for the quarter ending 2020-03-31 was -$307.83K.
- NEUROPATHIX, INC. net income (loss) available to common stockholders, basic for fiscal 2020 was -$4.54M.
- NEUROPATHIX, INC. net income (loss) available to common stockholders, basic for fiscal 2019 was -$3.44M, a 467.63% decline from fiscal 2018.
- NEUROPATHIX, INC. net income (loss) available to common stockholders, basic for fiscal 2018 was $936.82K.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$2.17M derived: sum of 2 quarters · filed 2021-03-30 | -$4.23M derived: sum of 3 quarters · filed 2021-03-30 | -$4.54M 10-K · filed 2021-03-30 |
| 2020-09-30 | -$610.81K 10-Q · filed 2020-11-12 | -$2.67M derived: sum of 2 quarters · filed 2020-11-12 | -$2.98M 10-Q · filed 2020-11-12 | -$3.71M derived: sum of 4 quarters · filed 2021-03-30 |
| 2020-06-30 | -$2.06M 10-Q · filed 2020-08-12 | -$2.37M 10-Q · filed 2020-08-12 | -$3.10M derived: sum of 3 quarters · filed 2021-03-30 | -$4.18M derived: sum of 4 quarters · filed 2021-03-30 |
| 2020-03-31 | -$307.83K 10-Q · filed 2020-05-14 | -$1.04M derived: sum of 2 quarters · filed 2021-03-30 | -$2.12M derived: sum of 3 quarters · filed 2021-03-30 | -$2.91M derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-12-31 | -$731.45K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$1.82M derived: sum of 2 quarters · filed 2021-03-30 | -$2.60M derived: sum of 3 quarters · filed 2021-03-30 | -$3.44M 10-K · filed 2021-03-30 |
| 2019-09-30 | -$1.08M 10-Q · filed 2020-11-12 | -$1.87M derived: sum of 2 quarters · filed 2020-11-12 | -$2.71M 10-Q · filed 2020-11-12 | -$3.89M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$782.08K 10-Q · filed 2020-08-12 | -$1.63M 10-Q · filed 2020-08-12 | -$2.80M derived: sum of 3 quarters · filed 2020-08-12 | -$3.60M derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | -$845.97K 10-Q · filed 2020-05-14 | -$2.02M derived: sum of 2 quarters · filed 2020-05-14 | -$2.82M derived: sum of 3 quarters · filed 2020-05-14 | |
| 2018-12-31 | -$1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$1.98M derived: sum of 2 quarters · filed 2020-03-30 | $936.82K 10-K · filed 2020-03-30 | |
| 2018-09-30 | -$799.26K 10-Q · filed 2019-11-13 | $2.11M 10-Q · filed 2019-11-13 |